Gossamer Bio, Inc.
GOSSBiotechnology
$10.38−2.90%As of Oct 30vs prior close
- P/E (TTM)
- –
- From 52W high
- −96.58%
- EPS (LTM)
- -$0.70
- Revenue (LTM)
- $53.3M
- Net margin
- -235.00%
- Dividend yield
- 0.00%
Nomior Score
4
Distressed LaggardBottom 1% of the scored universe
Growth27
Quality31
Value34
Momentum9
Resilience18
Growth
$53.3Mrevenue, LTM
YE22 $0LTM $53.3M
Connections
Revenue to profitQ2 YE26
The operating loss was 282% of revenue, narrower by 55 pts on a year.
Who owns it
1fund